| Non-Muscle Invasive Bladder Carcinoma studied in …STUDIED_INderived100 of 100show fewer |
|---|
| → studied in | NCT06770582Phase 2 · recruiting Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial · condition mapped ONTOLOGY_EXACT · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06833073Phase 2 · recruiting A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011) · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06919965Phase 3 · recruiting A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05316155Phase 1/Phase 2 · active not recruiting Study of Erdafitinib Intravesical Delivery System for Localized Bladder Cancer · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06211764Phase 3 · active not recruiting A Study of TAR-200 Versus Intravesical Chemotherapy in Participants With Recurrent High-Risk Non-Muscle-Invasive Bladder Cancer (HR-NMIBC) After Bacillus Calmette-Guérin (BCG) · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06319820Phase 3 · recruiting A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06877676approved for marketing Pre-Approval Expanded Access Study for TAR-200 Treating Physician Use · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07309445recruiting A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07800507Phase 1/Phase 2 · not yet recruiting Trop2-Targeted Near-Infrared Fluorescence Imaging-Guided Precise Resection of Non-Muscle Invasive Bladder Cancer · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07804056Phase 3 · recruiting A Study to Investigate the Efficacy and Safety of Alpha1H as a Neoadjuvant Therapy in Participants With Low- to Intermediate-Risk/Low-Grade Papillary Non-Muscle Invasive Bladder Cancer · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06733363Phase 2 · recruiting A Cruciferous Vegetable Eating Program for the Reduction of Cancer Recurrence and Progression in Patients With Non-muscle Invasive Bladder Cancer · condition mapped ONTOLOGY_EXACT · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05796375Phase 2 · recruiting Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05538663Phase 3 · active not recruiting Intravesical BCG vs GEMDOCE in NMIBC · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07777848Phase 2 · not yet recruiting A Study to Evaluate the Efficacy and Safety of RAG-01 as Monotherapy and in Combination With Chemotherapy in Patients With Non-muscle Invasive Bladder Cancer (NMIBC). · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05014139Phase 1 · terminated A Study of Intravesical Enfortumab Vedotin For Treatment of Patients With Non-muscle Invasive Bladder Cancer (NMIBC) · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06503614Phase 2 · recruiting A Trial of Durvalumab (MEDI4736) Plus Monalizumab in Non-Muscle-Invasive Bladder Cancer · condition mapped PROBABILISTIC · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07817173NA · not yet recruiting Feasibility of HISA During TURBT for NMIBC · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06990061NA · recruiting Radiotherapy for BCG-unresponsive Non-muscle-invasive Carcinoma in Situ (CIS) Bladder Cancer: an Open-label, Single-arm, Multicentre, Phase 2 Study · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07798479completed Age and Bladder Cancer Outcomes After BCG Treatment: A Multicenter Study · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07781956NA · not yet recruiting Home-Based Supportive Care Program for NMIBC Patients Receiving Intravesical Perfusion: Construction and Preliminary Application · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07480356Phase 3 · recruiting Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer · condition mapped ONTOLOGY_EXACT · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07758881NA · not yet recruiting Evaluating the Safety and Performance of the Eight Medical Hyperthermia System IV 1.0 for HIVEC in NMIBC. · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07763197recruiting Sample Collection for Ongoing Research and Product Evaluation Study - Non-muscle Invasive Bladder Cancer (SCORE-NMIBC) · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04164082Phase 2 · active not recruiting Testing the Addition of an Anti-cancer Drug, Pembrolizumab, to the Usual Intravesical Chemotherapy Treatment (Gemcitabine) for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder Cancer · condition mapped ONTOLOGY_EXACT · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04179162Phase 1/Phase 2 · active not recruiting Bacillus Calmette-Guérin (BCG) and Gemcitabine in People With High-Grade Non-Muscle Invasive Bladder Cancer That Came Back After BCG Treatment · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04752722Phase 1/Phase 2 · recruiting LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05483868Phase 1 · active not recruiting A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07749924NA · not yet recruiting Active Surveillance Versus Adjuvant Intravesical Chemotherapy in Liquid Biopsy-Defined Low-Shedding Intermediate-Risk NMIBC · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07000084Phase 3 · recruiting Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy · condition mapped CURATED_BROADER · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07225127recruiting Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2 · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07728474NA · recruiting LCS103 Herbal Formula for Secondary Prevention of Non-Muscle Invasive Urothelial Carcinoma of the Bladder · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07725796Phase 1 · not yet recruiting A Phase 1 Dose-escalation Study of UGN-501 Administered Intravesically in Adult Participants With Recurrent NMIBC · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07207824Phase 3 · recruiting DV+BCG in HER2-Expressing, BCG-Naïve High-Risk NMIBC · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07424287Phase 3 · recruiting A Study of Intravesical SHR-1501 Combination With BCG Versus Investigator-selected Chemotherapy in Subjects With BCG-unresponsive NMIBC · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05521698Phase 1 · recruiting A Randomized Trial of Bicalutamide in Non-Muscle Invasive Bladder Cancer · condition mapped ONTOLOGY_EXACT · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07302230NA · recruiting Home-Based Physical Activity Program With Digital App Versus Health Education Group for Improving Physical Activity Among Patients With Non-muscle Invasive Bladder Cancer, The EMPOWER Trial · condition mapped CURATED_BROADER · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07646145Phase 2 · recruiting Disitamab Vedotin Plus Intravesical Mitomycin C in HER2-Expressing Intermediate- to High-Risk Non-Muscle-Invasive Bladder Cancer · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02106572Phase 3 · terminated Therapeutic Instillation of Mistletoe · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07551544Phase 3 · withdrawn ANKTIVA Plus BCG Versus BCG Monotherapy In Participants With BCG-Naïve/BCG-Exposed High-Grade Non-Muscle Invasive Papillary Bladder Cancer · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06810141available ResQ132EX-NMIBC: Expanded Access Use of Recombinant Bacillus Calmette-Guérin in Nonmuscle Invasive Bladder Cancer · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07322263Phase 2 · recruiting Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07529639not yet recruiting Tumor Budding and T1 Substaging in Urothelial Bladder Cancer · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07511517active not recruiting BladMetrix Urine Test for Monitoring Recurrence in Non-Muscle Invasive Bladder Cancer · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07505615Phase 1/Phase 2 · completed A Phase I-II Study of Novel Oncolytic Virus VG161 Via Intravesical Instillation for BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06704191Phase 1/Phase 2 · recruiting In-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE Trial · condition mapped ONTOLOGY_EXACT · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06800963Phase 1/Phase 2 · recruiting ResQ133A-NMIBC: Intravesical Recombinant Mycobacterium (rMBCG) in Participants With NMIBC Eligible to Receive Intravesical Tice BCG · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07474519Phase 4 · recruiting Studying the Relationship of Patient Positioning and Intravesical Bacillus Calmette Guerin Dwell Time to Improve the Treatment of Non-muscle Invasive Bladder Cancer · condition mapped ONTOLOGY_EXACT · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06173349Phase 1 · recruiting PLZ4-Coated Paclitaxel-Loaded Micelles for the Treatment of Patients With Recurrent or Refractory Non-Muscle Invasive Bladder Cancer · condition mapped CURATED_BROADER · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07445308Phase 1/Phase 2 · not yet recruiting The Study is to Evaluate the Safety and Tolerability of SPGL008 Alone or in Combination With BCG in the Patients With NMIBC, and to Determine the RP2D of SPGL008 Alone or in Combination With BCG.To Evaluate the Preliminary Efficacy of SPGL008 Alone or in Combination With BCG. · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05375903Phase 1 · completed A Phase 1 Dose-escalation Study of UGN-301 in Patients With Recurrent Non-muscle Invasive Bladder Cancer (NMIBC) · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07339761NA · recruiting Supporting Sexual Health in Bladder Cancer Patients: A Sequential Mixed-Methods Intervention Study · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05962541Phase 4 · recruiting Vesical Imaging-Reporting and Data System (VI-RADS) Followed by Photodynamic Trans-urethral Resection of Bladder Tumours (PDD-TURBT) to Avoid Secondary Resections (Re-TURBT) in Non-Muscle Invasive Bladder Cancers (NMIBCs) · condition mapped ONTOLOGY_EXACT · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06396533recruiting Increasing Pre-Surgical Identification of Muscle Invasive Tumor Evaluations Prior to Planned Cystectomy (INSITE) · condition mapped ONTOLOGY_EXACT · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06829823Phase 2 · not yet recruiting Clinical Trial of Ablation Therapy in Participants With Intermediate-Risk Non-Muscle Invasive Papillary Bladder Cancer · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03914794Phase 2 · completed A Study of Pemigatinib in Non-muscle Invasive Bladder Cancer Patients With Recurrent Low- or Intermediate-Risk Tumors · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07187063NA · recruiting Using Urine Tumor DNA to De-Intensify Surveillance in Non-Muscle Invasive Bladder Cancer · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06351904Phase 1 · recruiting A Study of RAG-01 in Patients With Non-muscle-invasive Bladder Cancer (NMIBC) Who Have Failed Bacillus Calmette Guérin (BCG) Therapy · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06181266Phase 1 · active not recruiting A Phase 1/1b Study of ZH9 Treatment in Patients With Non-Muscle Invasive Bladder Cancer · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07122414Phase 1/Phase 2 · recruiting A Study of Intravesical FL115 Alone or in Combination With BCG in Non-Muscle Invasive Bladder Cancer · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07064863Phase 1/Phase 2 · not yet recruiting A Tumor Immune Biomarker Guided Approach for Improving Response to BCG in Patients With High-risk NMIBC. · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06991868recruiting A Multicenter Prospective Cohort Study on Monitoring Recurrence of Urothelial Carcinoma Based on Detection of Urinary Microscopic Residual Disease (MRD) · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06982690NA · not yet recruiting Anesthesia Modality and Oncologic Outcomes in High-Risk NMIBC: A Randomized Trial · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06766266Phase 1 · recruiting Irinotecan Liposomes Combined with Epirubicin in Recurrent Non-muscle Invasive Bladder Urothelium Carcinoma After Anthracyclines Treatment · condition mapped ONTOLOGY_EXACT · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06889623NA · recruiting Immediate Chemotherapy Following Resection for High-Risk Non-Muscle-Invasive Bladder Cancer · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06735287NA · recruiting A Bladder-Sparing Treatment Strategies of Large-Volume Non-Muscle-Invasive Bladder Cancer · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06696794Phase 3 · recruiting Investigating the Efficacy and Safety of Neoadjuvant Intravesical Instillation of Mitomycin C in Treating High-risk NMIBC Patients · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06186414Phase 1 · recruiting A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SIM0237 Alone or in Combination with BCG in NMIBC · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06630871Phase 2 · not yet recruiting A Clinical Trial Evaluating the Efficacy and Safety of Disitamab Vedotin Plus Tislelizumab Combined with Re-TURBT in the Treatment of HER-2-high Expression(2+-3+) Non-muscle Invasive Bladder Cancer At High-risk and Very High-risk. · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06588179Phase 1/Phase 2 · not yet recruiting SHR-1501 Combined With SHR-2005 for High-Risk Non-Muscle Invasive Bladder Cancer Which is Not Completely Resectable by TURBt · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02773849Phase 3 · completed ADSTILADRIN (=INSTILADRIN) in Patients With High-Grade, Bacillus Calmette-Guerin (BCG) Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC) · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04496219Phase 2 · completed Acupuncture for the Treatment of Intravesical BCG-Related Adverse Events in High-Risk Non-muscle Invasive Bladder Cancer · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06167356recruiting Study on the Occurrence of Possible Relapses and on the Quality of Life in Patients Who Underwent TURBK. · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05176145NA · unknown Demonstration of the Medical Interest of the VisioCyt® Artificial Intelligence Test · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06069453NA · terminated Hyaluronic Acid Sodium Salt and Hydeal-D in the Management of LUTS After TURBT for NMIBC. · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03379909Phase 2 · recruiting Phase II Study of Oral Metformin for Intravesical Treatment of Non-muscle-invasive Bladder Cancer · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06020807completed Analytical Specificity of Bladder EpiCheck Test in Healthy Population and Urology Patients Without Prior History or Evidence of Bladder Cancer · condition mapped ONTOLOGY_EXACT · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05946369completed Neutrophils to Lymphocytes Ratio in Predicting the Response to BCG in Non-muscle Invasive Bladder Cancer · condition mapped ONTOLOGY_EXACT · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05943379Phase 2 · recruiting RC48-ADC in Combination With Gemcitabine in High Risk NMIBC Subjects · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05084586NA · unknown Comparison of the Efficacy and Safety of Continuous and Single-Dose Intravesical Epirubicin Instillation · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03839472NA · withdrawn Continuous Bladder Irrigation Following Transurethral Resection of Bladder Tumors · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04730232Phase 2 · unknown Tilelizumab Combined With Nab-Paclitaxel for High-Risk Non-Muscle-Invasive Urothelial Bladder Carcinoma Which is Not Completely Resectable · condition mapped ONTOLOGY_EXACT · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03091764completed Evaluation of a Patient-Reported Symptom Index for NMIBC · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02009332Phase 1/Phase 2 · completed Phase 1/2 Study of ABI-009 in Nonmuscle Invasive Bladder Cancer · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03719300Phase 2 · terminated Codex: Study of Inodiftagene Vixteplasmid (BC-819) in Unresponsive NMIBC · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03167151Phase 1/Phase 2 · terminated Pembrolizumab in Intermediate Risk Recurrent Non-muscle Invasive Bladder Cancer (NMIBC) · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03672240Phase 1/Phase 2 · completed Study of APL-1202 in Non-Muscle Invasive Bladder Cancer Patients Who Are Resistant to One Induction Course of BCG Treatment · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00595088Phase 2 · completed Phase 2b, Trial of Intravesical DTA-H19/PEI in Patients With Intermediate-Risk Superficial Bladder Cancer · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03148158unknown Assessment Of Bladder Tumors Stage And Grade By Outpatient Flexible Cystoscopy Performed By Urology Resident · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01687244Phase 2 · completed Intravesical Administration of rAd-IFN/Syn3 in Patients With BCG-Refractory or Relapsed Bladder Cancer · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03038321Phase 4 · unknown Solifenacin, Levofloxacin or Lornoxicam, Which Is Ideal for Management of Intravesical Instillation BCG Side Effects? · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03121768unknown A New Prognostic Model for Predicting the Outcome of Patients With Non-muscle Invasive Bladder Cancer (NMIBC) · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00734994early Phase 1 · completed Mitomycin C With Hyperthermia and Intravesical Mitomycin C to Treat Recurrent Bladder Cancer · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02007005Phase 1/Phase 2 · completed Maximum Tolerable Concentration of abnobaVISCUM Fraxini Intravesically in Patients With Superficial Bladder Cancer · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01939756Phase 1/Phase 2 · completed Intravesical Natural Baobab Oil in the Management of BCG-induced Lower Urinary Tract Symptoms · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00322699Phase 1/Phase 2 · completed Sequential Whole Bladder Photodynamic Therapy (WBPDT) in the Management of Superficial Bladder Cancer · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01149174Phase 3 · completed Preoperative Intravesical Electromotive Mitomycin-c for Primary Non-muscle Invasive Bladder Cancer · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00782587Phase 1 · completed Study of Immediate Post-Operative Intravesical Instillation of Chemophase® in Patients With Superficial Bladder Cancer · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00816075Phase 2/Phase 3 · unknown Efficacy of Distilled Water Versus Mitomycin C on Preventing Recurrences of Bladder Cancer After Transurethral Resection · condition mapped CURATED_BROADER · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00192049Phase 2 · completed A Randomized Study Comparing Single Agent Gemcitabine Intravesical Therapy Versus Mitomycin C in Patients With Intermediate Risk Superficial Bladder Cancer · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00191711Phase 2 · completed Intravesical Gemcitabine Instillation Followed by Transurethral Resection for the Treatment of Patients With Superficial Bladder Cancer at Low Risk. · condition mapped ALIAS · 100 trials mapped (63 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |